Galectin Therapeutics Inc. (NASDAQ:GALT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Benjamin Carson Sr Other companies: Sinclair, Inc. (Director · Since at least Jun 11, 2024); Covenant Logistics Group, Inc. (Director · Since at least Jul 7, 2021); D.R. Horton, Inc. (Director · Since at least Apr 20, 2021); Vaccinogen Inc (Director · Aug 22, 2014 – Apr 20, 2015 · Past); Costco Wholesale Corporation (Director · Apr 27, 2006 – Feb 27, 2015 · Past) | Director · Since at least Dec 7, 2023 |
| Gilbert F. Amelio Other companies: 5BARz International Inc (Director · Nov 21, 2013 – Jul 8, 2014 · Past); InterDigital, Inc. (Director · Mar 1, 2011 – Apr 29, 2015 · Past); Jazz Technologies Inc (Chairman and CEO, Director · May 16, 2007 – Dec 17, 2007 · Past); AT&T Inc. (Director · Jan 31, 2006 – Apr 30, 2013 · Past) | Independent Director · Since at least Feb 12, 2009 |
| Dale H. Conaway Other companies: Bioxytran, Inc. (Director · Since at least Jul 1, 2020); Boston Therapeutics Inc (Director · Apr 4, 2014 – May 15, 2015 · Past) | Director · Mar 9, 2006 – Feb 8, 2009 · Past |
| Gilbert S. Omenn Other companies: Amesite Inc. (Director · Since at least Sep 25, 2020); Elicio Therapeutics, Inc. (Director · Feb 4, 2021 – Jun 9, 2022 · Past) | Director · Since at least Dec 14, 2017 |
| Pol F. Boudes Other companies: Protalix BioTherapeutics, Inc. (de) (Director · Since at least Jan 1, 2020); Amicus Therapeutics Inc (Chief Medical Officer · Jun 15, 2010 – Jun 4, 2012 · Past) | Chief Medical Officer · Mar 2, 2020 – Jan 24, 2024 · Past |
| Anthony Don Squeglia Other companies: Boston Therapeutics Inc (Chief Financial Officer · Dec 3, 2013 – Mar 10, 2015 · Past) | Chief Financial Officer · Oct 1, 2007 – Feb 2, 2010 · Past |
| Henry Brem Other companies: Alseres Pharmaceuticals Inc (Director · Dec 6, 2007 – Jan 14, 2009 · Past) | Independent Director · Since at least Mar 12, 2026 |
| Jack W Callicutt Other companies: Vystar Corporation (Chief Financial Officer · Apr 12, 2010 – Mar 14, 2011 · Past) | Chief Financial Officer · Since at least Jul 1, 2013 |
| Andrew Volosov | Vice President, Clinical Pharmacology and Pharmacokinetics · Since at least Nov 4, 2026 |
| Benjamin S. Carson | Independent Director · Since at least Nov 5, 2026 |
| Elissa J. Schwartz | Independent Director · Since at least Aug 31, 2020 |
| Harold Shlevin | Director · Since at least Jan 26, 2023 |
| Herman Paul Pressler | Director · May 26, 2011 – Mar 12, 2015 · Past |
| Jack W. Callicutt | Chief Financial Officer · Since at least Oct 6, 2026 |
| James Theophile Gourzis | Director · Feb 8, 2009 – Feb 8, 2009 · Past |
| Jerald K Rome | Director · Mar 7, 2013 – Mar 28, 2013 · Past |
| Jim Wilkins | Head of CMC and Pharmaceutical Development · Since at least Nov 4, 2026 |
| Joel Lewis | Chief Executive Officer (CEO) and President · Since at least Dec 14, 2017 |
| Kary Eldred | Director · Since at least May 22, 2018 |
| Kevin D. Freeman | Vice Chairman of the Board · Since at least May 26, 2011 |
| Khurram Jamil | Chief Medical Officer · Since at least Aug 1, 2024 |
| Maureen Foley | Chief Operating Officer · Mar 9, 2006 – Feb 2, 2010 · Past |
| Mildred S Christian | Director · Mar 9, 2006 – Feb 25, 2009 · Past |
| Richard A. Zordani | Independent Director · Since at least Nov 5, 2026 |
| Richard A Zordani Jr | Director · Since at least Jan 24, 2024 |
| Richard E. Uihlein | Director · Since at least Jan 24, 2024 |
| Sharisse Brutto | Vice President, Project Management · Since at least Nov 5, 2026 |
| Theodore Daniel Zucconi | Director · Dec 14, 2017 – Apr 16, 2018 · Past |